Last reviewed · How we verify

NCT06142721

Comparison of Walking Parameters Between Idiopathic Toe Walking and Independent Walking Diparetic Cerebral Palsy

Completed Last updated 21 November 2023
What this trial tests

trial testing 3D Gait Analysis in Gait Disorders in Children in 51 participants. Completed in 15 January 2023.

Timeline
15 September 2022
Primary endpoint
15 January 2023
15 January 2023

Quick facts

Lead sponsorBiruni University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment51
Start date15 September 2022
Primary completion15 January 2023
Estimated completion15 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Biruni University

Who can join

Adults 3 to 18, any sex, with Gait Disorders in Children or Cerebral Palsy Spastic Diplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the observational study is to compare static, kinematic and kinetic parameters with normal gait parameters in cases with Idiopathic toe walking (ITW) and Diparetic Cerebral Palsy (DCP) who have Gross Motor Function Classification System 1 level with the 3D Gait Analysis method, and to enable the early diagnosis of DCP and ITW. Male and female cases aged between 3-18 years will be included. This study will be carried out at Acıbadem Altunizade Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of 3D Gait Analysis

Trials testing the same drug.

Other recruiting trials for Gait Disorders in Children

Currently open trials in the same condition.

Other Biruni University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06142721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing